---
layout: post
title: "Listing of Patent Information in the Orange Book; Establishment of a Public Docket; Request for Comments; Reopening of Comment Period"
date: 2026-02-05 19:08:49 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2021-05327
original_published: 2021-03-16 00:00:00 +0000
significance: 8.00
---

# Listing of Patent Information in the Orange Book; Establishment of a Public Docket; Request for Comments; Reopening of Comment Period

**Published:** February 05, 2026 19:08 UTC
**Source:** Federal Register
**Original Published:** March 16, 2021 00:00 UTC
**Document Number:** 2021-05327

## Summary

The Food and Drug Administration (FDA or the Agency) is reopening the comment period for the notice entitled "Listing of Patent Information in the Orange Book; Establishment of a Public Docket; Request for Comments" that appeared in the Federal Register of June 1, 2020. The notice announced the establishment of a docket to solicit comments on the listing of patent information in the FDA publication "Approved Drug Products With Therapeutic Equivalence Evaluations" (commonly known as the "Orange Book"). The Agency is taking this action in response to the recently enacted Orange Book Transparency Act of 2020, which was signed into law on January 5, 2021.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2021/03/16/2021-05327/listing-of-patent-information-in-the-orange-book-establishment-of-a-public-docket-request-for)
- API: https://www.federalregister.gov/api/v1/documents/2021-05327

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
